We generated the shRNAs targeting CD44 and screened shCD44-1 with the best knockdown efficiency to downregulate CD44 expression in CALCR-overexpressed 786-O cells (Supplementary Figure 1F), and detected the promoting role of CALCR on RCC cells. This evidence concerns the gene CD44 and renal cell carcinoma.